Humana Inc. (HUM)
NYSE: HUM · Real-Time Price · USD
252.86
+3.33 (1.33%)
At close: May 12, 2025, 4:00 PM
252.50
-0.36 (-0.14%)
After-hours: May 12, 2025, 7:50 PM EDT
Humana Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for Humana stock have an average target of 285.4, with a low estimate of 250 and a high estimate of 326. The average target predicts an increase of 12.87% from the current stock price of 252.86.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Humana stock from 21 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
Buy | 5 | 5 | 5 | 5 | 6 | 5 |
Hold | 17 | 17 | 17 | 17 | 15 | 15 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 24 | 24 | 23 | 23 | 22 | 21 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Hold Maintains $325 → $305 | Hold | Maintains | $325 → $305 | +20.62% | May 12, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $290 | Hold | Reiterates | $290 | +14.69% | May 1, 2025 |
Oppenheimer | Oppenheimer | Buy Maintains $300 → $310 | Buy | Maintains | $300 → $310 | +22.60% | May 1, 2025 |
Baird | Baird | Hold Maintains $270 → $300 | Hold | Maintains | $270 → $300 | +18.64% | Apr 15, 2025 |
Barclays | Barclays | Hold Maintains $270 → $322 | Hold | Maintains | $270 → $322 | +27.34% | Apr 11, 2025 |
Financial Forecast
Revenue This Year
128.06B
from 117.76B
Increased by 8.75%
Revenue Next Year
131.71B
from 128.06B
Increased by 2.85%
EPS This Year
16.53
from 9.98
Increased by 65.66%
EPS Next Year
13.97
from 16.53
Decreased by -15.50%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 134.4B | 146.7B | 160.5B | ||
Avg | 128.1B | 131.7B | 143.3B | ||
Low | 122.4B | 118.6B | 123.3B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 14.2% | 14.5% | 21.9% | ||
Avg | 8.7% | 2.8% | 8.8% | ||
Low | 3.9% | -7.4% | -6.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 17.85 | 17.37 | 29.18 | ||
Avg | 16.53 | 13.97 | 21.63 | ||
Low | 15.90 | 5.91 | 17.77 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 78.9% | 5.0% | 108.9% | ||
Avg | 65.7% | -15.5% | 54.9% | ||
Low | 59.3% | -64.3% | 27.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.